Ripple’s Fate Hangs in the Balance: SEC Unveils Timeline for Remedies Phase, XRP Under Intense Market Scrutiny

"Judge Sets Timeline for Ripple's Legal Battle Against SEC: Examination to Begin in February 2024"

The timeline set by Judge Torres on Monday, November 13, 2023, has established February 12, 2024, as the start date for a comprehensive examination of Ripple’s alleged offenses. The Securities and Exchange Commission (SEC) will then present its brief on potential remedies for Section 5 violations by March 13, 2024. Ripple Labs is expected to submit its opposition to the SEC’s propositions by April 12, with the SEC’s final response due by April 29, 2024. This sequence of filings will mark the conclusion of the remedies phase of the litigation.

Both parties have agreed to a 90-day discovery period to address all issues related to the remedies. With a previous ruling in July 2023, which deemed Ripple’s institutional sales of XRP as an investment contract, Ripple now potentially faces a significant fine that could amount to $770 million.

These legal proceedings have created uncertainty surrounding XRP’s market position and price dynamics. Recently, XRP encountered resistance at the $0.68 price level, and there are speculations about a possible 10% decline if it falls below the $0.59 support level.

In a separate but related incident, XRP experienced a temporary price surge, reaching $0.66, following a deceptive BlackRock XRP Trust filing that led to a dramatic 250% increase in trading volume.

The outcome of this legal battle is highly anticipated within the cryptocurrency community and could have far-reaching implications for the industry. It comes at a time when regulatory scrutiny of digital assets is intensifying globally. The final judgment in this case is expected in July 2024, coinciding closely with the Wave of Innovation 2024 XRP Gold Coast Conference scheduled for April. Attorney John Deaton is set to discuss the intricacies of this high-profile case during the conference.

Please note that this article was generated with the support of AI and reviewed by an editor.

Martin Reid

Martin Reid

Leave a Replay

Scroll to Top